Photocure : Asieris' NDA For Cevira Accepted By NMPA For Regulatory Review In China
13/5 03:21
(RTTNews) - Photocure ASA said its partner Asieris Pharmaceuticals communicated that the National Medical Products Administration (NMPA) has accepted its new drug application or NDA for the regulatory review of Cevira (APL-1702, Hexaminolevulinate Hydrochloride Ointment Photodyna...